Oral vinorelbine plus capecitabine (oral vincap) combination in patients with advanced breast cancer (ABC). A phase II study of the GOIM (Gruppo Oncologico dell'Italia Meridionale)

Annals of Oncology

Volumn 17, Issue SUPPL. 7, 2006, Pages

  Lorusso, Vito ^a   Spada, M ^b   Giampaglia, M ^b   Misino, A ^b   Calabrese, R ^b   Latorre, A ^b   Monticelli, G ^a   Guida, M ^b   Sambiasi, D ^b   Colucci, G ^b  

^a VITO FAZZI HOSPITAL   (Italy)

^b NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

Author keywords

Breast cancer; Capecitabine; Oral chemotherapy; Vinorelbine

Indexed keywords

ANTHRACYCLINE; CAPECITABINE; DEXAMETHASONE; NAVELBINE; ONDANSETRON; TAXANE DERIVATIVE;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; BLOOD TOXICITY; BREAST CANCER; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONSTIPATION; DRUG ACTIVITY; DRUG DOSE REGIMEN; FATIGUE; HAND FOOT SYNDROME; HUMAN; NAUSEA AND VOMITING; NEUROTOXICITY; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; STOMACH PAIN; STOMATITIS; THROMBOCYTOPENIA;

EID: 33745613545     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdl942     Document Type: Article

References (22)

1. De Vita VT, Hellman S, Rosenberg SA. Cancer: Principles and Practice of Oncology. Philadelphia: J.B. Lippincott Co. 1993; 1264-1332.
2. Tripathy D. Systemic therapy for advanced breast cancer. Breast J 2004; 10 (Suppl 1): 26-27.
3. Sledge GW Jr, Antman KH. Progress in chemotherapy for metastatic breast cancer. Sem Oncol 1992; 19: 317-332.
4. Ahmann DL, Schaid DJ, Bisel HF et al. The effect on survival of initial chemotherapy in advanced breast cancer. Polychemotherapy versus single drug. J Clin Oncol 1987; 5: 1928-1932.
5. Jassem J, Pienkowski T, Pluzanska A et al. Doxorubicin and paclitaxel versus fluorouracil, doxorubicin, and cyclophosphamide as first-line therapy for women with metastatic breast cancer: Final results of a randomized phase III multicenter trial. J Clin Oncol 2001; 19: 1707-1715.
6. Nabholtz JM, Reese DM, Lindsay MA, Riva A. Docetaxel in the treatment of breast cancer: An update on recent studies. Semin Oncol 2002; 29 (3 Suppl 12): 28-34.
7. Crown J, D'Eieras V, Kaufmaun M et al. Chemotherapy for metastatic breast cancer - report of an European expert panel. Lancet Oncol 2002; 3: 719-727.
8. Monfardini S, Beda M, Fratino L. Breast cancer: Single agents chemotherapy. Tumori 2002; 88 (1 Suppl 1): S55-56.
9. Budman D, Meropol N, Reigner B et al. Preliminary studies of a novel oral fluoropyrimidinecarbamate: Capecitabine. J Clin Oncol 1998; 16: 1795-1802.
10. Mackean M, Planting A, Twelves C et al. A phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer. J Clin Oncol 1998; 16: 2977-2985.
11. Schilsky RL. Pharmacology and clinical status of capecitabine. Oncology (Huntingt) 2000; 14: 1297-1306.
12. O'Shaughnessy JA, Blum J, Moiseyenko et al. Randomized, open-label, phase II trial of oral capecitabine (Xeloda) vs. a reference arm of intravenous CMF (cyclophosphamide, methotrexate and 5-fluorouracil) as first-line therapy for advanced/metastatic breast cancer. Ann Oncol 2001; 12: 1247-1254.
13. Blum JL, Jones SE, Buzdar AU et al. Multicenter phase II trial of Xeloda (Capecitabine) in Paclitaxel - refractory Metastatic Breast Cancer (MBC). J Clin Oncol 1999; 17: 485-493.
14. Blum JL, Dieras V, Lo Russo PM et al. Multicenter phase II study of capecitabine in taxane-pretreated metastatic breast carcinoma. Cancer 2001; 92: 1759-1768.
15. O'Shaughnessy J. Clinical experience of capecitabine in metastatic breast cancer. Eur J Cancer 2002; 38 (Suppl 2):10-14.
16. Fumoleau P, Delgado FM, Delozier T et al. Phase II trial of weekly intavenous vinorelbine in first-line Advanced Breast Cancer chemotherapy. J Clin Oncol 1993; 7: 1245-1252.
17. Romero A, Rabinovich MG, Vallejo CT et al: Vinorelbine as first line chemotherapy for metastatic breast carcinoma. J Clin Oncol 1994; 12: 336-341.
18. Garcia-Conde J, Lluch A, Marin M et al. Phase II trial of weekly i.v. vinorelbine as first line chemotherapy for metastatic breast carcinoma. Ann Oncol 1994; 5: 854-857.
19. Lorusso V, Crucitta E, Silvestris N et al. A phase I study of capecitabine in combination with vinorelbine in advanced breast cancer. Clin Breast Cancer 2003; 4: 138-141.
20. Ahn JH, Kim SB, Kim TW. Capecitabine and vinorelbine in patients with metastatic breast cancer previously treated with anthracycline and taxane. J Korean Med Sci 2004; 19: 547-553.
21. Welt A, von Minkwiz G, Oberhoff C et al. Phase I/II study of capecitabine and vinorelbine in pretreated patients with metastatic breast cancer. Ann Oncol 2005: 64-69.
22. Nole F, Catania C, Sanna G et al. Dose-finding and pharmacokinetic study of an all-oral combination regimen of oral vinorelbine and capecitabine for patients with metastatic breast cancer. Ann Oncol 2006; 17: 322-329.